ANFIELD CAPITAL MANAGEMENT, LLC Halozyme Therapeutics, Inc. Transaction History

ANFIELD CAPITAL MANAGEMENT, LLC portfolio value:

$45,000
portfolio value

ANFIELD CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-10.14%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +3.57% 39 shares -3K $39.54 1.13K
Q2 2022 share Increase +16.65% 156 shares 11K $44 1.09K
Q1 2022 share 0.00% 0 shares 0 $39.88 267
Q4 2021 share Increase +1171.43% 246 shares 10K $40.32 267
Q3 2021 share Increase 0.00% 21 shares 1K $40.68 21